VF
CMMB

Virtu Financial’s Chemomab Therapeutics CMMB Stock Holding History

Virtu Financial’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,933
Closed -$18K – 1718
2025
Q4 		$18K Buy
+10,933
New +$29K ﹤0.01% 1446
2025
Q2 		– Sell
-7,701
Closed -$34K – 1543
2025
Q1 		$34K Buy
7,701
+4,090
+113% +$28.7K ﹤0.01% 1055
2024
Q4 		$26K Buy
+3,611
New +$22.8K ﹤0.01% 1256
2024
Q1 		– Sell
-6,452
Closed -$13K – 1498
2023
Q4 		$13K Buy
+6,452
New +$17K ﹤0.01% 1381
2022
Q1 		– Sell
-5,610
Closed -$155K – 1565
2021
Q4 		$155K Buy
+5,610
New +$199K 0.02% 937
2021
Q3 		– Sell
-3,295
Closed -$251K – 1563
2021
Q2 		$251K Buy
+3,295
New +$322K 0.02% 834
2021
Q1 		– Sell
-1,088
Closed -$120K – 1654
2020
Q4 		$120K Buy
1,088
+883
+431% +$85.1K 0.01% 1013
2020
Q3 		$15K Buy
+205
New +$13.9K ﹤0.01% 939
2019
Q4 		– Sell
-204
Closed -$30K – 1484
2019
Q3 		$30K Buy
+204
New +$39.7K ﹤0.01% 1253

Other funds holding CMMB

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $161M AUM

Virtu Financial's CMMB Position: Q1 2026 in Review

Virtu Financial sold out of Chemomab Therapeutics (CMMB) in Q1 2026, closing a stake of 10,933 shares — an estimated $18K sold.

Virtu Financial first reported a position in CMMB in Q3 2019 and held it in 9 quarters. The position peaked at $251K in Q2 2021. 15 funds tracked by Wall St. Rank hold CMMB as of Q1 2026.

  • Virtu Financial reported no remaining Chemomab Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,933 Chemomab Therapeutics shares in Q1 2026, an estimated $18K.
  • Virtu Financial first reported a position in Chemomab Therapeutics in Q3 2019 and held it in 9 quarters.
  • Virtu Financial's Chemomab Therapeutics position peaked at $251K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.